Abstract:Background Exposure to air pollution, a leading contributor to the global burden of disease, can cause economic losses. Driven by clean air policies, the air quality in China, one of the most polluted countries, has improved rapidly since 2013. This has enabled a unique, quasi-experiment to assess the economic impact of air pollution empirically. Methods and findings Using a series of nation-scale longitudinal surveys in 2011, 2013, and 2015, we first examined the questionnaire-based medical expenditure changes before and after the policy intervention for air pollution. Using a state-of-the-art estimator of the historical concentration of particulate matters with diameter less than 2.5 mu m (particulate matter (PM)(2.5)), we further quantified the association between household medical expenditure and PM2.5 using mixed-effect models of the repeated measurements from 26,511 households in 126 cities. Regression models suggest a robust linear association between reduced PM2.5 and saved medical expenditures, since the association did not vary significantly across models with different covariate adjustments, subregions, or subpopulations. Each 10 mu g/m(3) reduction in PM2.5 was associated with a saving of 251.6 (95% CI: 30.8, 472.3; p-value = 0.026) Yuan in per capita annual medical expenditure. However, due to limitations in data quality (e.g., self-reported expenditures), and imperfect control for unmeasured confounders or impact from concurrent healthcare reform in China, the causality underlying our findings should be further confirmed or refuted. Conclusion In this study, we observed that compared with the PM2.5 reduction in 2013, the PM2.5 reduction in 2017 was associated with a saving of 552 (95% CI: 68, 1036) Yuan / (person x year), or approximately 736 billion Yuan (equivalent to 111 billion US dollar) per year nationally, which is equivalent to approximately 1% of the national gross domestic product of China. Author summary Why was this study done? Exposure to air pollution is a leading contributor to the global burden of disease. Mitigating air pollution can protect public health, so that can save medical expenditures on relevant diseases. The association between air pollution exposure and medical expenditures has been insufficiently studied. China conducted a series of clean air actions since 2013 and rapidly reduced the concentration of PM2.5, a major air pollutant. What did the researchers do and find? We examined medical expenditure changes before and after the policy intervention for air pollution, using a longitudinal nation-scale surveys in 2011, 2013, and 2015. After 2013, the PM2.5 concentration decreased more rapidly, but the medical expenditures increased more slowly. We also associated household medical expenditure to PM2.5 concentration using a mixed-effect models. We found that each 10 mu g/m3 reduction in PM2.5 was associated with a saving of 251.6 Yuan in per capita annual medical expenditure. What do these findings mean? Air pollution was evidenced as a risk factor associated with increased medical expenditure. China's clean air actions could bring a direct health benefit by saving medical expenditure.

Burden of lung cancer attributable to ambient fine particles and potential benefits from air quality improvements in Beijing, China: A population-based study

An Assessment of the Potential Health Benefits of Realizing the Goals for PM 10 in the Updated Chinese Ambient Air Quality Standard

Drivers of Improved PM2.5 Air Quality in China from 2013 to 2017.

The PM2.5 Concentration Reduction Improves Survival Rate of Lung Cancer in Beijing.

Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China

Burden of lung cancer attributed to particulate matter pollution in China: an epidemiological study from 1990 to 2019

Potential causal links of long‐term air pollution with lung cancer incidence: From the perspectives of mortality and hospital admission in a large cohort study in southern China

The epidemiological trends in the burden of lung cancer attributable to PM2.5 exposure in China

[Health Impact Attributable to the Control of PM2.5 Pollution in China During 2013-2017].

Clean air actions in China, PM<sub>2.5</sub> exposure, and household medical expenditures: A quasi-experimental study

Potential Health Benefits of Controlling Dust Emissions in Beijing.

Air quality improvements and health benefits from China’s clean air action since 2013

Associations of incident female breast cancer with long-term exposure to PM2.5 and its constituents: Findings from a prospective cohort study in Beijing, China

Ambient PM2.5 and Annual Lung Cancer Incidence: A Nationwide Study in 295 Chinese Counties

Long- and short-term health benefits attributable to PM 2.5 constituents reductions from 2013 to 2021: A spatiotemporal analysis in China

Substantial Reductions in Ambient PAHs Pollution and Lives Saved As a Co-Benefit of Effective Long-Term PM2.5 Pollution Controls

Exploring the Burden of PM2.5-Related Deaths and Economic Health Losses in Beijing

[Lung cancer deaths attributable to ambient PM(2.5) exposure in 2016 in China]

Associations Between Atmospheric PM2.5 Exposure and Carcinogenic Health Risks: Surveillance Data from the Year of Lowest Recorded Levels in Beijing, China.

Exploring Sources and Health Risks in Beijing PM2.5 in 2019 and 2020

Quantifying Public Health Benefits of Environmental Strategy of PM2.5 Air Quality Management in Beijing–Tianjin–Hebei Region, China